Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ecoaida S R L has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to a distinct examiner within a distinct art unit. FAY, ZOHREH ALEMZADEH is the busiest examiner for the company, managing the 1 pending office action. This profile reflects a highly focused prosecution effort with only 1 pending matter.
The data confirms that a distinct examiner is responsible for the 1 pending office action in the portfolio. FAY, ZOHREH ALEMZADEH is the sole examiner listed, and the action is housed within the art unit. This singular focus suggests a straightforward prosecution path for the company's current intellectual property. For practitioners, this profile represents a minimal administrative footprint with no complexity from examiner or art unit diversity. The concentration of the portfolio into a single pending action within the Biotechnology & Pharmaceuticals area simplifies the management of the company's patent interests.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAY, ZOHREH ALEMZADEH | 1 | 52.1% | -6.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18712903 | NEW ANTI MICROBIAL CARBON DOTS | FAY, ZOHREH ALEMZADEH | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18712903 | NEW ANTI MICROBIAL CARBON DOTS | FAY, ZOHREH ALEMZADEH | 1616 | §102§103 | Non-Final OA | — | Pending | May 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEcoaida S R L has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Zohreh Alemzadeh Fay has the most, with 1 of Ecoaida S R L's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
